SOLIAIR is a privately held, Israeli-based alternative medicine company whose founder has developed a mixture of plant extracts that show promise in the treatment of chronic obstructive pulmonary disease.
SOLIAIR intends to market and sell private-label naturopathic and homeopathic dietary supplements. The companys mission is to provide alternative medicines and natural supplements using an efficient supply chain to lower the cost for consumers. Its products will include ginseng, ginkgo, and various antioxidants.
Cumulative Funding Raised Over Time ($)
Employees Over Time
SOLIAIR Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Nov 24, 2013
www.drugdiscoveryonline.com
SOLIAIR - New Respiratory And Lung Diseases Drug Discovery Released